Choosing a GLP-1 Clinic · FormBlends network
Choose a GLP-1 clinic that fits you, and know the questions to ask before you pay.
In-person, telehealth or hybrid: how each works, what a good intake looks like, the red flags, and a quiz that scores your priorities without naming a provider.
- 6
- care models compared, one page each
- Care models compared on intake, follow-up, pharmacy and cost.
- Same standard
- telehealth is held to the in-person standard of care
- Telehealth is held to the in-person standard of care. A shortcut intake is a red flag.
- 30
- telehealth companies sent FDA warning letters on compounded-drug claims
- Telehealth companies warned by the FDA in March 2026 over compounded-drug claims.
Start here
Three ways in, depending on what you need right now
- 01Clinic fit quizTen questions about your priorities; a ranked explanation of which care model fits and what each costs you.
- 02Four ways to get GLP-1 care, comparedThere are four ways to get GLP-1 care: a weight clinic, your own doctor, online only, or a mix of both.
- 03Browse care models6 pages, most recently updated September 4, 2026
Interactive
The calculator
Each runs in your browser, shows its formula, and prints a dated assumptions note. Nothing you type leaves the page.
Reading
Start with these
Each page opens with a plain-English summary, a figure drawn from the data, the numbers that matter, and what it means if you're considering treatment.
Care Models
Four ways to get GLP-1 care, compared
You'll get: There are four ways to get GLP-1 care: a weight clinic, your own doctor, online only, or a mix of both.
In-person obesity medicine, primary care, telehealth-only and hybrid care side by side: what each can do, what each cannot, who it suits, and where society guidance draws lines.
Money
How GLP-1 clinics charge: membership, per-visit and bundled medication
You'll get: Clinics charge three ways: a monthly membership, a fee per visit, or one bundled price that includes the drug.
The three ways clinics build a bill, what each one hides, a worksheet for laying two offers side by side, the questions that reveal what a fee actually includes, and where to check medication prices independently.
Reference
How to use the clinic fit quiz
You'll get: The quiz asks ten questions about what you want and ranks four care models, showing why each gained or lost points.
What the quiz measures, how the weights were set, what a result does and does not mean, and how to take the ranking to a real clinic.
Safety
Red flags in GLP-1 clinic marketing
You'll get: Guaranteed weight loss, no diet needed, and results for everyone are claims the FTC calls always false.
Claims that should end the conversation: guaranteed weight loss, no medical history needed, 'FDA-approved compounded', hidden pharmacies, fake urgency, testimonials standing in for evidence. Each with the regulator or label that says why.
Your Visit
What a good GLP-1 intake includes
You'll get: A proper intake takes a weight and health history and asks directly about medullary thyroid cancer in your family.
The history, labs and contraindication screening a proper intake covers before a GLP-1 is prescribed, drawn from the Wegovy and Zepbound labels and society guidance, and how to tell when an intake has skipped something.
Live updates
What changed since this site was written
Sources checked October 23, 2026, refreshed every six hours.
Newest on PubMed
Papers indexed in the last year matching GLP-1 care delivery (90 in total).
- Real-world observational study evaluating metabolic and kidney outcomes in patients living with chronic kidney disease and type 2 diabetes mellitus with obesity prescribed tirzepatide
Diabet Med · October 19, 2026 · PubMed 42897718
- A Retrospective Chart Review of Tirzepatide and Semaglutide Use in Prediabetes Management and Cardiometabolic Outcomes in a Rural Primary Care Setting
J Dr Nurs Pract · October 15, 2026 · PubMed 42880879
- US Healthcare Professionals' Management of MASH and Knowledge of GLP-1, GIP, and Glucagon Receptor Agonists
Clin Transl Gastroenterol · October 6, 2026 · PubMed 42837671
- Considerations and challenges in microdosing of GLP-1-based receptor agonists
Expert Opin Pharmacother · October 5, 2026 · PubMed 42788826
- GLP-1 receptor agonists in dermatology: Prescribing frameworks, access, and the emerging pipeline
Clin Dermatol · September 23, 2026 · PubMed 42777891
FDA and enforcement tracker
FormBlends research feed, data as of September 4, 2026.
September 1, 2026 · Adverse-event report update
FDA GLP-1 concerns page updated: 990 adverse-event reports for compounded semaglutide and >730 for compounded tirzepatide (as of May 31, 2026); border screening and fake-pharmacy labelsAugust 28, 2026 · Label or price event
FDA approves Mounjaro (tirzepatide) to reduce MACE risk in adults with type 2 diabetes (SURPASS-CVOT)August 27, 2026 · Court decision
Fifth Circuit affirms summary judgment for FDA in both GLP-1 shortage cases (Nos. 25-10600 tirzepatide; 25-10758 semaglutide)August 24, 2026 · FDA warning letter
FDA warning letters to five peptide vendors: Peak Performance Peptides (735127), Royal Peptides (734884), NuScience Peptides (733652), Peptide Partners (735063), TXP Innovations dba Tex Peptides (735067)August 24, 2026 · FDA warning letter
FDA warning letter: TXP Innovations LLC dba Tex Peptides (Unapproved New Drugs/Misbranded)
Compounded price index
Median all-in cash price per 28 days across providers, as of September 3, 2026.
- semaglutide, month 1 at 0.25 mg/week
- $197
- median of 14 providers
- semaglutide, month 4 at 1 mg/week
- $199
- median of 13 providers
- tirzepatide, month 1 at 2.5 mg/week
- $268
- median of 14 providers
- tirzepatide, month 4 at 5 mg/week
- $299
- median of 12 providers
- September 3, 2026: Index, All, baseline 51 rows. First weekly snapshot. Changes against this baseline will be listed here with the date they were observed.
PubMed lists come from NCBI E-utilities and are not reviewed by us before they appear. Feeds are FormBlends Research data (CC BY 4.0); FormBlends sells compounded GLP-1 drugs and appears in the price index under the same rules as every other provider. Compounded drugs are not FDA approved.
Browse
Sections
18 pages across 5 sections, each sourced to a label, a trial or a dated manufacturer page.
Care Models
You'll get: 6 sourced pages, each with a plain-English opener
In-person obesity medicine, primary care, telehealth-only and hybrid care side by side: what each can do,...
Your Visit
You'll get: 5 sourced pages, each with a plain-English opener
The history, labs and contraindication screening a proper intake covers before a GLP-1 is prescribed, drawn...
Money
You'll get: 2 sourced pages, each with a plain-English opener
The three ways clinics build a bill, what each one hides, a worksheet for laying two offers side by side,...
Safety
You'll get: 3 sourced pages, each with a plain-English opener
Claims that should end the conversation: guaranteed weight loss, no medical history needed, 'FDA-approved...
Reference
You'll get: 2 sourced pages, each with a plain-English opener
What the quiz measures, how the weights were set, what a result does and does not mean, and how to take the...
Start with the model, then the clinic
Most people compare clinics before they have decided what kind of care they need. Do it the other way round. Decide whether you need an exam in a room, whether your conditions need close follow-up, whether visits must run through insurance, and how far you will travel. That narrows you to a model. Then use the questions on this site to test any clinic of that model, and use formblendsreviews.com for the programs it has scored.
What this site will not do
It does not rank clinics, name a best one, or tell you whether you should take a GLP-1. It links to the state rules at formblendsdirectory.com rather than restating them, to the lab schedule at formblendslabs.com, to pharmacy vetting at formblendscompounding.com, and to prices at formblendspricing.com. Compounded GLP-1s are not FDA approved and are not interchangeable with brand products; the site says so wherever it matters.